Document Type : Research Paper
Authors
1 Assistant Professor of Surgery, Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 Associate Professor of Radiology, Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Abstract
This is a descriptive study that was conducted in 2020 by reviewing the clinical records of all women with breast cancer over the age of 70 over a ten-year period ending in 2020 with a clinical record of 183 patients. Demographic information, type of tumor pathology, clinical stage of the tumor, status of hormone receptors and tumor HER2 protein, type of surgery, type of adjuvant treatment were extracted from the files and used. In 88 non-metastatic patients, there were 90 lymph nodes positive, of which 33 (37.5%) had no estrogen receptor and 55 (62.5%) had estrogen receptor. The most systemic treatment in patients with estrogen receptor-free tumor was chemotherapy (81.8%) and in patients with estrogen receptor tumor, chemotherapy plus hormone therapy (58.2%). there were 40 non-metastatic lymph node-negative patients, of which 9 (22.5%) had no estrogen receptor and 31 (77.5%) had estrogen receptor. The most systemic treatment received in patients without estrogen receptor was only chemotherapy (77.8%) and in patients with estrogen receptor tumor was only hormone therapy (54%). It seems that the most common stage of the disease in elderly women and over 70 years is type IIB, which is also more common in these elderly women with breast cancer; Therefore, it is necessary to pay attention to these points in treatment planning
Keywords
Main Subjects
2. S.M. Pourmortazavi, M. Taghdiri, V. Makari, M.R. Nasrabadi, Spectrochim., J.Acta Mol. Biomol. Spectros., 139,1249 (2015).
3. B. Ajitha, Y.A.K. Reddy, P.S. Reddy, J.Mater, Sci. Eng. Chem., 49,373 (2015).
4. M.S. Abdel-Aziz, M.S. Shaheen, El-Nekeety, A.A. Abdel-Wahhab, J. Saudi Chem. Soc., 356,363(2014).
5. D.A. Kumar, V. Palanichamy, S.M. Roopan, Spectrochim. Acta Mol. Biomol. Spec- tros., 127 (2014).
6. E. Bohloulbandi, P. Ahmadi Aval, Int. J. new chem., 356, 364 (2021).
7. N. Amini, G. Amin, Z. Jafari Azar, J.Nanomed. Res., 2,57(2017).
8. T. S. Nasiri Moghaddam, F. Roya Nikmaram, R. Ahmadi. Int. J. new chem., 72,77(2017).
9. R. Desai, V. Mankad, S. K. Gupta, K. Nanosci, J.Nanotechnol., 4, 30 (2012).
10. S. Agnihotri, S. Mukherji, S. Mukherji, J. R. Soc. Chem., 4, 3974 (2014).
11. K. khan, S. Javed., J. Sci. pro. 104(2021).
)